CELEX ONCOLOGY LIMITED

CELEX ONCOLOGY LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameCELEX ONCOLOGY LIMITED
    Company StatusDissolved
    Legal FormPrivate limited company
    Company Number 10535801
    JurisdictionEngland/Wales
    Date of Creation
    Date of Cessation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of CELEX ONCOLOGY LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is CELEX ONCOLOGY LIMITED located?

    Registered Office Address
    101 New Cavendish Street
    1st Floor South
    W1W 6XH London
    United Kingdom
    Undeliverable Registered Office AddressNo

    What are the latest accounts for CELEX ONCOLOGY LIMITED?

    Last Accounts
    Last Accounts Made Up ToDec 31, 2021

    What are the latest filings for CELEX ONCOLOGY LIMITED?

    Filings
    DateDescriptionDocumentType

    Final Gazette dissolved via voluntary strike-off

    1 pagesGAZ2(A)

    Current accounting period extended from Dec 31, 2022 to May 31, 2023

    1 pagesAA01

    First Gazette notice for voluntary strike-off

    1 pagesGAZ1(A)

    Registered office address changed from 64 New Cavendish Street London W1G 8TB England to 101 New Cavendish Street 1st Floor South London W1W 6XH on Apr 03, 2023

    1 pagesAD01

    Application to strike the company off the register

    2 pagesDS01

    Confirmation statement made on Dec 19, 2022 with no updates

    3 pagesCS01

    Total exemption full accounts made up to Dec 31, 2021

    7 pagesAA

    Confirmation statement made on Dec 19, 2021 with no updates

    3 pagesCS01

    Total exemption full accounts made up to Dec 31, 2020

    7 pagesAA

    Confirmation statement made on Dec 19, 2020 with no updates

    3 pagesCS01

    Total exemption full accounts made up to Dec 31, 2019

    8 pagesAA

    Confirmation statement made on Dec 19, 2019 with no updates

    3 pagesCS01

    Termination of appointment of Leif Helth Jensen as a director on Aug 05, 2019

    1 pagesTM01

    Total exemption full accounts made up to Dec 31, 2018

    7 pagesAA

    Confirmation statement made on Dec 20, 2018 with no updates

    3 pagesCS01

    Total exemption full accounts made up to Dec 31, 2017

    6 pagesAA

    Confirmation statement made on Dec 20, 2017 with updates

    4 pagesCS01

    Resolutions

    Resolutions
    37 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Statement of capital following an allotment of shares on May 19, 2017

    • Capital: GBP 116.12
    3 pagesSH01

    Registered office address changed from 9 Park View Road London N3 2BJ United Kingdom to 64 New Cavendish Street London W1G 8TB on May 10, 2017

    1 pagesAD01

    Director's details changed for Mr Leif Helth Jense on May 10, 2017

    2 pagesCH01

    Resolutions

    Resolutions
    36 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Incorporation

    59 pagesNEWINC
    Associated Filings
    CategoryDateDescriptionType
    capitalDec 21, 2016

    Statement of capital on Dec 21, 2016

    • Capital: GBP 100
    SH01

    Who are the officers of CELEX ONCOLOGY LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    COHEN, Laurence John
    New Cavendish Street
    1st Floor South
    W1W 6XH London
    101
    United Kingdom
    Director
    New Cavendish Street
    1st Floor South
    W1W 6XH London
    101
    United Kingdom
    United KingdomBritish195986490001
    DJAMGOZ, Mustafa Bilgin Ali, Professor
    Park View Road
    N3 2BJ London
    9
    United Kingdom
    Director
    Park View Road
    N3 2BJ London
    9
    United Kingdom
    United KingdomBritish221129260001
    FALTUM, Carsten Kronsbjerg
    New Cavendish Street
    1st Floor South
    W1W 6XH London
    101
    United Kingdom
    Director
    New Cavendish Street
    1st Floor South
    W1W 6XH London
    101
    United Kingdom
    DenmarkDanish221129280001
    JENSEN, Leif Helth
    Park View Road
    N3 2BJ London
    9
    United Kingdom
    Director
    Park View Road
    N3 2BJ London
    9
    United Kingdom
    SwitzerlandDanish221129290002

    Who are the persons with significant control of CELEX ONCOLOGY LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Professor Mustafa Bilgin Ali Djamgoz
    Park View Road
    N3 2BJ London
    9
    United Kingdom
    Dec 21, 2016
    Park View Road
    N3 2BJ London
    9
    United Kingdom
    No
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 50% but not more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 50% but not more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0